Spray it up your nose, or inject it under the skin, and within days your skin turns a deep, even, suspiciously permanent bronze. No sun required. TikTok calls it the āvacation peptide.ā The compound is melanotan II, and its more famous nickname, the āBarbie drug,ā has been showing up in dermatology journals since at least 2010 ā for the tan, plus a side effect serious enough that it later spun off its own FDA-approved libido drug. The name conjures exactly who youād picture: young, female, chasing an Instagram-ready glow. But found something else entirely ā average age 39, more than three in four men, most introduced to it through gym and bodybuilding circles years before any tanning trend existed online. The Barbie drug describes the branding. It doesnāt describe whoās behind it.
Buying it isnāt straightforward, by design. The name āmelanotanā itself covers at least two distinct synthetic compounds, several product variations, and an unknown number of mislabelled vials that may contain neither ā . TikTok has banned the hashtags #melanotan and #melanotan2, so the same vial now circulates under generic, unbranded packaging, indistinguishable from a bottle of vitamins, while , to stay beneath the radar of the financial networks processing their sales. In Australia, where melanotan is legally prescription-only, ā and when they asked one seller to explain, the company quietly edited its own website mid-investigation. Promoters have their own incentive too: discount codes and affiliate links mean a cut of every sale for whoeverās posting them. a company had simply offered her free nasal sprays to post about, no questions asked; she now says she should have been more careful about what she put in front of an audience full of teenagers. studied by dermatologists even mention the product is unregulated. Whether financial relationships get disclosed any more often than that, tellingly, nobody has bothered to measure.
Hereās the risk that should worry you most. A 41-year-old man bought melanotan over the counter from a bodybuilding supplement store, where heād been a regular customer for months. After one injection, he developed a painful, unrelenting erection that lasted 22 hours ā , caused by the same pathway responsible for the drugās libido effect. Doctors drained roughly 700 millilitres of blood from his penis and pushed medication to nearly the maximum recommended dose before it resolved. A month later, his erectile function still hadnāt recovered. He told the doctors writing up his case that if heād known this could happen, he never would have touched the drug. Nothing on the label had told him.
None of this is really a debate about whether melanotan is safe. When , safety wasnāt the first thing on their mind ā several treated the nausea and flushing as proof the product was working, not a reason to stop. The real puzzle is why someone trusts a strangerās syringe, recommended in a fifteen-second video, over a dermatologistās warning they may never even encounter. Thatās not a pharmacology problem. Itās a trust problem ā and the trust didnāt disappear. It moved.
Three things are doing that moving, together. Platforms reward attention, not accuracy: of news on social media found false claims spread farther, faster, and more broadly than true ones, because confident and novel beats hedged and careful. Sellers reward promotion, not honesty: peptide vendors run public affiliate programs offering creators a flat commission, sometimes a discount code, on every sale their link generates. And audiences reward familiarity over credentials: found nearly two-thirds of people who already trust a favourite lifestyle influencer would extend that trust to a brand the influencer vouches for, even one theyād otherwise distrust. None of these three actors needs to be acting in bad faith. The system produces bad outcomes anyway.
Melanotan shows exactly how. The research program began in the 1980s at the University of Arizona, searching for a sunless tan that could protect fair skin from cancer. A later variant ā melanotan II, shorter, more potent, and with a particular affinity for receptors governing sexual arousal and appetite ā turned out to be something the researchers hadnāt planned for at all. That origin is what makes the modern lie so effective: , more than a third claim melanotan actually protects against it, some pitched explicitly as a sunscreen alternative. It isnāt pure fabrication. Itās a true fact from the 1980s, rotated 180 degrees and pointed at an audience the original researchers never imagined, used to wave off a contemporary melanoma risk thatās anything but theoretical. That particular lie isnāt new, either. , ordered it to stop, watched it keep selling anyway, and spent nine years pursuing a case that ended in a felony conviction and a lifetime ban for the owner. Nine years, one company. The same claim now runs across thousands of anonymous accounts, with no single owner left to debar.
Thatās the real story behind every flashy peptide trend, melanotan included: not a system thatās too slow to catch up, but trust that has already relocated somewhere institutions were never built to watch. Dermatologists are starting to see the moles. Regulators are still issuing one warning letter at a time. Both are doing exactly what theyāre trained to do. Theyāre just no longer anywhere near where the actual decisions are being made.
JuliaĀ Nevski is a fourth-year Medical Sciences student at Western University, specializing in One Health. She is the founder of Substrate, an independent evidence synthesis project examining off-label and grey-market compounds circulating outside regulated medical channels.
Part of the OSS mandate is to foster science communication and critical thinking in our students and the public. We hope you enjoy these pieces from our Student Contributors and welcome any feedback you may have!
